Impact of baseline tumor size on overall survival in patients with RR-DTC treated with lenvatinib (SELECT)

Kiyota, N; Tahara, M; Robinson, B; Schlumberger, M; Sherman, S; Leboulleux, S; Lee, EK; Suzuki, T; Ren, M; Fushimi, K; Wirth, L

ANNALS OF ONCOLOGY, 2021; 32 (): S296